Sanofi SNY
NASDAQ SNY
$41.30 +0.07 (+0.17%)
As of: Oct 1, 2026 · 10:19 AM EDT

Sanofi (SNY) Operating Income (2009 - 2026)

Updated

Sanofi's Operating Income was $1.22 billion in the quarter ended Jun 30, 2026, down 27.0% from $1.67 billion a year earlier and down 51.0% from the prior quarter.

Analysis

Sanofi (SNY) Operating Income (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Sanofi's Operating Income was $3.74 billion through Jun 30, 2026, down 56.4% year-over-year; for the year ended Dec 31, 2025, it was $7.17 billion, down 8.7% from the prior year.

  • Operating Income shows a five-year compound annual growth rate of -15.0% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Operating Income was $7.85 billion in the year ended Dec 31, 2024 (+4.3%), $7.53 billion in the year ended Dec 31, 2023 (-29.7%), $10.71 billion in the year ended Dec 31, 2022 (+11.4%) and $9.62 billion in the year ended Dec 31, 2021 (-40.3%).
  • Quarterly Operating Income has moved between -$8.59 billion (the quarter ended Dec 31, 2025) and $8.63 billion (the quarter ended Sep 30, 2025) over five years.
  • Compared with a year earlier, Operating Income was higher in five of the last seven quarters, with growth averaging 14.0%.
  • The best year-over-year quarter for Operating Income over five years was the quarter ended Dec 31, 2022 (growth of 148.3%); the worst was the quarter ended Dec 31, 2024 (a decline of 91.8%).
  • Per Business Quant data, SNY's Operating Income in the three quarters before the quarter ended Jun 30, 2026 was $2.48 billion (quarter ended Mar 31, 2026), -$8.59 billion (quarter ended Dec 31, 2025) and $8.63 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 7.14 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 6.43 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 3.16 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.39 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Sanofi 50.28 Bn 17.06 Bn 10.79 Bn 1.22 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.22 Bn
Mar 31, 2026 2.48 Bn
Dec 31, 2025 -8.59 Bn
Sep 30, 2025 8.63 Bn
Jun 30, 2025 1.67 Bn
Mar 31, 2025 2.40 Bn
Dec 31, 2024 612.31 Mn
Sep 30, 2024 3.89 Bn
Jun 30, 2024 1.65 Bn
Mar 31, 2024 1.34 Bn
Dec 31, 2023 7.49 Bn
Sep 30, 2023 3.50 Bn
Jun 30, 2023 2.02 Bn
Mar 31, 2023 2.64 Bn
Dec 31, 2022 4.19 Bn
Sep 30, 2022 2.75 Bn
Jun 30, 2022 1.53 Bn
Mar 31, 2022 2.69 Bn
Dec 31, 2021 1.69 Bn
Sep 30, 2021 3.58 Bn
API Access

Sanofi Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=SNY&period=max&api_key=YOUR_API_KEY